Vera Therapeutics, Inc. · NASDAQ:VERA

Sofinnova Venture Partners X, L.P. ("SVP X") reported a 3.90% stake in Vera Therapeutics, Inc. (Schedule 13D/A)

Event Dec 10, 2025 · Filed Mar 5, 2026

Sofinnova Venture Partners X, L.P. ("SVP X") reported a 3.90% stake in Vera Therapeutics, Inc., 2,793,987 shares, with active intent on Dec 10, 2025. Filed Mar 5, 2026 (Schedule 13D/A).

Stake
3.90%
Shares
2,793,987
Intent
Active
What changed
Stake changed
Filed together
5 holders

The filing in full

HolderStakeShares
Sofinnova Venture Partners X, L.P. ("SVP X")3.90%2,793,987
Sofinnova Management X, L.P. ("SM X LP")3.90%2,793,987
Sofinnova Management X-A, L.L.C. ("SM X LLC")3.90%2,793,987
Dr. James I. Healy ("Healy")3.90%2,793,987
Dr. Maha Katabi ("Katabi")4.00%2,847,837

Source

View original at SEC

Related